CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy
about
Biomarkers for cognitive impairment and dementia in elderly people.Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus reportOngoing search for diagnostic biomarkers in idiopathic normal pressure hydrocephalus.Venous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysisBiomarkers in chronic adult hydrocephalus.Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH.Multiplicity of cerebrospinal fluid functions: New challenges in health and diseaseFluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus.Both total and phosphorylated tau are increased in Alzheimer's disease.Directional diffusion of corticospinal tract supports therapy decisions in idiopathic normal-pressure hydrocephalus.Long-term outcome in 109 adult patients operated on for hydrocephalus.Differences in cerebrospinal fluid dynamics do not affect the levels of biochemical markers in ventricular CSF from patients with aqueductal stenosis and idiopathic normal pressure hydrocephalus.High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS/MS.CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus.Neurological symptoms and signs in adult aqueductal stenosis.Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study.Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosis.A qualitative study of the consequences of 'hidden dysfunctions' one year after a mild stroke in persons <75 years.
P2860
Q30370745-B7293F22-BD85-4DE8-B3EA-C8118EAEE0A4Q33721681-1F5AF1F9-7604-4EFB-A24D-8A6A47D6C4B3Q34115835-C2A6AE41-D877-421E-B655-1CEE8B41D2CCQ34750423-E86413AB-DC0B-41B2-B7D2-27D4B0BAFC9BQ35101048-C06116D9-D9FF-445B-9881-6D16F8678209Q36945742-8849D771-CF44-4D12-B5B1-8B098968A4B9Q37163564-DB5ECF0E-0137-4FB9-BBB9-16DC4EF4E836Q37693146-F9AE7B0F-6503-42A3-858B-7857448C9AACQ38534131-62FFEA42-600C-44D6-A412-7756334754FDQ41765446-DDF12329-7C28-4C10-A86C-79DBE1561290Q43619433-EE355508-E4E6-4E4E-81A5-23A78D8656DCQ44614825-DE68427B-E4D6-4829-9AFF-5E02E4396A49Q44704318-611ABFBA-A767-459C-A06A-81B99F25870BQ46360074-ABC897CB-791E-4A58-BA06-AE095E18524FQ46961181-6E1980FE-1755-4696-9E0A-094F905B37B4Q48326390-03F2FEDD-987E-445A-9142-5F81295DBA45Q48398819-402F3836-5696-4EC6-AD17-402014F8F978Q49122634-8E97DC08-82AE-4D6C-B4EF-296A5B1AE69EQ51932563-17ACA889-31E2-49FB-AA1D-0C383AD24CB3
P2860
CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
CSF sulfatide distinguishes be ...... rteriosclerotic encephalopathy
@ast
CSF sulfatide distinguishes be ...... rteriosclerotic encephalopathy
@en
type
label
CSF sulfatide distinguishes be ...... rteriosclerotic encephalopathy
@ast
CSF sulfatide distinguishes be ...... rteriosclerotic encephalopathy
@en
prefLabel
CSF sulfatide distinguishes be ...... rteriosclerotic encephalopathy
@ast
CSF sulfatide distinguishes be ...... rteriosclerotic encephalopathy
@en
P2093
P2860
P356
P1476
CSF sulfatide distinguishes be ...... rteriosclerotic encephalopathy
@en
P2093
Månsson JE
Tullberg M
Wikkelsø C
P2860
P356
10.1136/JNNP.69.1.74
P407
P577
2000-07-01T00:00:00Z